| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intervertebral Disc | 104 | 2023 | 217 | 13.150 |
Why?
|
| Spinal Fusion | 91 | 2023 | 518 | 12.090 |
Why?
|
| Cervical Vertebrae | 81 | 2023 | 352 | 10.480 |
Why?
|
| Lumbar Vertebrae | 112 | 2023 | 490 | 9.640 |
Why?
|
| Intervertebral Disc Degeneration | 42 | 2023 | 117 | 7.320 |
Why?
|
| Intervertebral Disc Displacement | 49 | 2023 | 121 | 6.990 |
Why?
|
| Diskectomy | 36 | 2023 | 195 | 5.650 |
Why?
|
| Spinal Diseases | 38 | 2023 | 150 | 5.050 |
Why?
|
| Radiculopathy | 18 | 2019 | 62 | 3.630 |
Why?
|
| Lordosis | 8 | 2023 | 42 | 3.360 |
Why?
|
| Spinal Stenosis | 21 | 2019 | 53 | 3.310 |
Why?
|
| Humans | 294 | 2023 | 29801 | 3.210 |
Why?
|
| Laminectomy | 21 | 2020 | 64 | 3.110 |
Why?
|
| Bone Screws | 22 | 2023 | 181 | 3.100 |
Why?
|
| Postoperative Complications | 25 | 2021 | 957 | 2.790 |
Why?
|
| Bone Morphogenetic Proteins | 26 | 2014 | 103 | 2.760 |
Why?
|
| Low Back Pain | 26 | 2023 | 139 | 2.670 |
Why?
|
| Spondylolisthesis | 9 | 2019 | 52 | 2.510 |
Why?
|
| Thoracic Vertebrae | 23 | 2017 | 112 | 2.480 |
Why?
|
| Middle Aged | 132 | 2022 | 9952 | 2.410 |
Why?
|
| Animals | 93 | 2023 | 4634 | 2.370 |
Why?
|
| Biomechanical Phenomena | 52 | 2023 | 680 | 2.340 |
Why?
|
| Range of Motion, Articular | 32 | 2023 | 707 | 2.310 |
Why?
|
| Spine | 18 | 2021 | 123 | 2.290 |
Why?
|
| Pedicle Screws | 5 | 2023 | 17 | 2.270 |
Why?
|
| Adult | 117 | 2022 | 8730 | 2.210 |
Why?
|
| Male | 145 | 2023 | 15844 | 2.180 |
Why?
|
| Female | 147 | 2023 | 16402 | 2.160 |
Why?
|
| Finite Element Analysis | 19 | 2023 | 44 | 2.070 |
Why?
|
| Tomography, X-Ray Computed | 28 | 2021 | 778 | 2.030 |
Why?
|
| Transforming Growth Factor beta | 14 | 2014 | 124 | 2.020 |
Why?
|
| Lumbosacral Region | 15 | 2023 | 73 | 1.970 |
Why?
|
| Imaging, Three-Dimensional | 10 | 2021 | 222 | 1.890 |
Why?
|
| Retrospective Studies | 45 | 2023 | 3325 | 1.850 |
Why?
|
| Internal Fixators | 13 | 2012 | 52 | 1.850 |
Why?
|
| Chondrocytes | 14 | 2019 | 203 | 1.810 |
Why?
|
| Decompression, Surgical | 14 | 2019 | 144 | 1.780 |
Why?
|
| Radiography | 46 | 2023 | 678 | 1.740 |
Why?
|
| Aged | 101 | 2023 | 9618 | 1.640 |
Why?
|
| Spinal Fractures | 17 | 2021 | 62 | 1.610 |
Why?
|
| Orthopedic Procedures | 12 | 2013 | 322 | 1.590 |
Why?
|
| Back Pain | 10 | 2022 | 63 | 1.590 |
Why?
|
| Bone Plates | 9 | 2009 | 55 | 1.560 |
Why?
|
| Proteoglycans | 30 | 2023 | 345 | 1.520 |
Why?
|
| Rabbits | 24 | 2023 | 283 | 1.520 |
Why?
|
| Magnetic Resonance Imaging | 44 | 2023 | 1246 | 1.490 |
Why?
|
| Bone Transplantation | 19 | 2018 | 227 | 1.450 |
Why?
|
| Disease Models, Animal | 20 | 2015 | 744 | 1.440 |
Why?
|
| Treatment Outcome | 46 | 2023 | 3557 | 1.430 |
Why?
|
| Artificial Intelligence | 5 | 2022 | 22 | 1.400 |
Why?
|
| Kyphosis | 6 | 2012 | 25 | 1.390 |
Why?
|
| Microsatellite Repeats | 3 | 2014 | 17 | 1.370 |
Why?
|
| Occipital Bone | 3 | 2016 | 13 | 1.330 |
Why?
|
| Genetic Variation | 3 | 2014 | 108 | 1.310 |
Why?
|
| Zygapophyseal Joint | 14 | 2021 | 44 | 1.220 |
Why?
|
| Contrast Media | 6 | 2017 | 125 | 1.170 |
Why?
|
| Bone Morphogenetic Protein 7 | 16 | 2015 | 63 | 1.160 |
Why?
|
| Atlanto-Occipital Joint | 3 | 2019 | 18 | 1.140 |
Why?
|
| Scoliosis | 3 | 2020 | 35 | 1.040 |
Why?
|
| Extracellular Matrix | 15 | 2023 | 75 | 0.990 |
Why?
|
| Cadaver | 23 | 2019 | 362 | 0.970 |
Why?
|
| Osseointegration | 5 | 2014 | 75 | 0.940 |
Why?
|
| Cells, Cultured | 32 | 2019 | 682 | 0.940 |
Why?
|
| Spinal Cord Diseases | 4 | 2019 | 52 | 0.940 |
Why?
|
| Models, Biological | 11 | 2012 | 347 | 0.930 |
Why?
|
| Stem Cell Transplantation | 4 | 2018 | 40 | 0.910 |
Why?
|
| Reoperation | 9 | 2020 | 927 | 0.890 |
Why?
|
| Fishes | 2 | 2014 | 4 | 0.890 |
Why?
|
| Cattle | 30 | 2018 | 218 | 0.890 |
Why?
|
| Notochord | 4 | 2008 | 5 | 0.870 |
Why?
|
| Joint Instability | 14 | 2013 | 389 | 0.850 |
Why?
|
| Biological Products | 3 | 2011 | 44 | 0.840 |
Why?
|
| Neck Pain | 4 | 2019 | 32 | 0.840 |
Why?
|
| Nucleus Pulposus | 3 | 2017 | 12 | 0.830 |
Why?
|
| Telemedicine | 5 | 2022 | 99 | 0.820 |
Why?
|
| Annulus Fibrosus | 3 | 2017 | 9 | 0.820 |
Why?
|
| Growth Substances | 5 | 2006 | 41 | 0.790 |
Why?
|
| Weight-Bearing | 15 | 2014 | 168 | 0.790 |
Why?
|
| Glycopyrrolate | 1 | 2021 | 5 | 0.750 |
Why?
|
| Patient Reported Outcome Measures | 8 | 2023 | 384 | 0.750 |
Why?
|
| Urinary Retention | 1 | 2021 | 11 | 0.740 |
Why?
|
| Total Disc Replacement | 3 | 2023 | 16 | 0.730 |
Why?
|
| Neurosurgical Procedures | 7 | 2009 | 152 | 0.730 |
Why?
|
| Spinal Neoplasms | 6 | 2019 | 36 | 0.730 |
Why?
|
| Cell Movement | 5 | 2020 | 104 | 0.730 |
Why?
|
| Orthopedics | 5 | 2013 | 129 | 0.720 |
Why?
|
| Microsurgery | 2 | 2019 | 40 | 0.720 |
Why?
|
| Atlanto-Axial Joint | 5 | 2013 | 18 | 0.710 |
Why?
|
| Risk Factors | 17 | 2022 | 2465 | 0.710 |
Why?
|
| Apoptosis | 3 | 2013 | 259 | 0.710 |
Why?
|
| Obesity | 3 | 2019 | 289 | 0.700 |
Why?
|
| Calcium Phosphates | 5 | 2014 | 27 | 0.700 |
Why?
|
| Arthroplasty, Replacement | 3 | 2006 | 149 | 0.700 |
Why?
|
| Spinal Nerve Roots | 12 | 2004 | 28 | 0.700 |
Why?
|
| Fracture Fixation, Internal | 6 | 2011 | 72 | 0.690 |
Why?
|
| Carotid Artery, Internal | 1 | 2019 | 11 | 0.680 |
Why?
|
| Hypoglossal Nerve | 1 | 2019 | 4 | 0.680 |
Why?
|
| Patient Discharge | 2 | 2020 | 151 | 0.670 |
Why?
|
| Prostheses and Implants | 6 | 2010 | 165 | 0.650 |
Why?
|
| Rotation | 12 | 2016 | 142 | 0.650 |
Why?
|
| Arthritis, Rheumatoid | 4 | 2013 | 363 | 0.640 |
Why?
|
| Bone Cements | 5 | 2007 | 90 | 0.640 |
Why?
|
| Interleukin-8 | 2 | 2016 | 32 | 0.640 |
Why?
|
| Cicatrix | 6 | 2006 | 12 | 0.640 |
Why?
|
| Genetics, Population | 3 | 2014 | 4 | 0.640 |
Why?
|
| Postural Balance | 1 | 2020 | 122 | 0.640 |
Why?
|
| Collagen Type II | 5 | 2018 | 33 | 0.630 |
Why?
|
| Fibroblasts | 2 | 2018 | 93 | 0.630 |
Why?
|
| Young Adult | 19 | 2021 | 1966 | 0.620 |
Why?
|
| Organometallic Compounds | 2 | 2017 | 14 | 0.610 |
Why?
|
| Bone Density | 11 | 2019 | 151 | 0.610 |
Why?
|
| Aorta | 2 | 2017 | 26 | 0.610 |
Why?
|
| Stress, Mechanical | 12 | 2013 | 169 | 0.600 |
Why?
|
| Disease Progression | 8 | 2017 | 812 | 0.590 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 282 | 0.590 |
Why?
|
| Ganglia, Spinal | 6 | 2016 | 58 | 0.580 |
Why?
|
| Salvage Therapy | 1 | 2017 | 36 | 0.580 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2017 | 30 | 0.580 |
Why?
|
| Bone Substitutes | 3 | 2014 | 26 | 0.580 |
Why?
|
| Adolescent | 23 | 2022 | 2331 | 0.580 |
Why?
|
| Cerebral Arteries | 1 | 2017 | 31 | 0.570 |
Why?
|
| Flumazenil | 1 | 2016 | 1 | 0.570 |
Why?
|
| Antidotes | 1 | 2016 | 6 | 0.560 |
Why?
|
| Drug Overdose | 1 | 2016 | 8 | 0.560 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2012 | 60 | 0.550 |
Why?
|
| Benzodiazepines | 1 | 2016 | 61 | 0.550 |
Why?
|
| Cell Transplantation | 4 | 2015 | 29 | 0.550 |
Why?
|
| Anesthetics, Local | 2 | 2016 | 92 | 0.550 |
Why?
|
| Interleukins | 1 | 2016 | 37 | 0.540 |
Why?
|
| Cartilage, Articular | 10 | 2015 | 534 | 0.540 |
Why?
|
| Cell Culture Techniques | 6 | 2013 | 45 | 0.530 |
Why?
|
| Tissue Engineering | 5 | 2018 | 36 | 0.530 |
Why?
|
| Follow-Up Studies | 17 | 2023 | 1859 | 0.530 |
Why?
|
| Mammals | 2 | 2023 | 26 | 0.520 |
Why?
|
| Osteotomy | 2 | 2020 | 164 | 0.520 |
Why?
|
| Epidural Space | 3 | 2016 | 24 | 0.510 |
Why?
|
| Collagen | 11 | 2023 | 102 | 0.510 |
Why?
|
| Computer Simulation | 8 | 2016 | 218 | 0.510 |
Why?
|
| Biocompatible Materials | 2 | 2014 | 105 | 0.510 |
Why?
|
| Spinal Cord Compression | 5 | 2023 | 31 | 0.510 |
Why?
|
| Disability Evaluation | 9 | 2019 | 327 | 0.510 |
Why?
|
| Surgeons | 3 | 2021 | 76 | 0.510 |
Why?
|
| Pain Measurement | 8 | 2019 | 468 | 0.510 |
Why?
|
| Cartilage | 3 | 2008 | 154 | 0.510 |
Why?
|
| Movement | 8 | 2011 | 145 | 0.510 |
Why?
|
| Pain, Postoperative | 4 | 2020 | 318 | 0.510 |
Why?
|
| Compressive Strength | 6 | 2012 | 29 | 0.500 |
Why?
|
| Bone Regeneration | 4 | 2011 | 75 | 0.490 |
Why?
|
| Models, Anatomic | 10 | 2018 | 52 | 0.490 |
Why?
|
| Sensitivity and Specificity | 11 | 2015 | 558 | 0.490 |
Why?
|
| Bass | 1 | 2014 | 1 | 0.490 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2014 | 4 | 0.490 |
Why?
|
| Ossification of Posterior Longitudinal Ligament | 1 | 2014 | 3 | 0.480 |
Why?
|
| Polymethyl Methacrylate | 5 | 2007 | 15 | 0.480 |
Why?
|
| Anatomy, Comparative | 1 | 2014 | 1 | 0.470 |
Why?
|
| Rats | 11 | 2018 | 873 | 0.470 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2014 | 46 | 0.470 |
Why?
|
| In Vitro Techniques | 10 | 2014 | 214 | 0.460 |
Why?
|
| Genetic Therapy | 5 | 2012 | 91 | 0.460 |
Why?
|
| Epidural Abscess | 2 | 2006 | 7 | 0.460 |
Why?
|
| Electrocoagulation | 2 | 2003 | 16 | 0.450 |
Why?
|
| Growth Plate | 3 | 2014 | 23 | 0.440 |
Why?
|
| RNA, Messenger | 8 | 2015 | 323 | 0.440 |
Why?
|
| Spinal Osteophytosis | 5 | 2007 | 14 | 0.430 |
Why?
|
| Dogs | 10 | 2007 | 261 | 0.430 |
Why?
|
| Musculoskeletal Diseases | 2 | 2023 | 41 | 0.430 |
Why?
|
| Aged, 80 and over | 35 | 2017 | 4930 | 0.430 |
Why?
|
| Medicare | 2 | 2023 | 123 | 0.410 |
Why?
|
| Anthropometry | 3 | 2011 | 38 | 0.410 |
Why?
|
| Durapatite | 3 | 2014 | 11 | 0.410 |
Why?
|
| Fractures, Ununited | 3 | 2009 | 19 | 0.410 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2021 | 221 | 0.410 |
Why?
|
| Elasticity | 6 | 2013 | 40 | 0.400 |
Why?
|
| Reproducibility of Results | 6 | 2016 | 801 | 0.400 |
Why?
|
| Fibronectins | 4 | 2015 | 31 | 0.400 |
Why?
|
| Interleukin-1 | 6 | 2014 | 79 | 0.390 |
Why?
|
| Osteoarthritis | 8 | 2010 | 366 | 0.390 |
Why?
|
| Proteins | 2 | 2011 | 71 | 0.390 |
Why?
|
| Polyethylene | 1 | 2012 | 119 | 0.380 |
Why?
|
| Regeneration | 3 | 2006 | 27 | 0.380 |
Why?
|
| Nerve Compression Syndromes | 6 | 2004 | 27 | 0.380 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2013 | 32 | 0.380 |
Why?
|
| Metals | 1 | 2012 | 149 | 0.380 |
Why?
|
| Republic of Korea | 4 | 2015 | 10 | 0.380 |
Why?
|
| Osteomyelitis | 2 | 2006 | 23 | 0.370 |
Why?
|
| High Mobility Group Proteins | 2 | 2007 | 3 | 0.370 |
Why?
|
| Signal Transduction | 10 | 2017 | 492 | 0.370 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2023 | 77 | 0.370 |
Why?
|
| Ossification, Heterotopic | 5 | 2014 | 41 | 0.370 |
Why?
|
| Homeostasis | 7 | 2014 | 84 | 0.360 |
Why?
|
| Time Factors | 13 | 2019 | 1640 | 0.360 |
Why?
|
| Diagnostic Imaging | 5 | 2006 | 90 | 0.360 |
Why?
|
| Sacrum | 4 | 2011 | 27 | 0.360 |
Why?
|
| Osteogenesis | 3 | 2005 | 103 | 0.360 |
Why?
|
| Bacterial Infections | 2 | 2006 | 66 | 0.350 |
Why?
|
| Patient Satisfaction | 5 | 2022 | 297 | 0.350 |
Why?
|
| Inflammation | 4 | 2023 | 347 | 0.350 |
Why?
|
| Tuberculosis, Spinal | 1 | 2009 | 2 | 0.340 |
Why?
|
| Osteoporosis | 5 | 2005 | 84 | 0.340 |
Why?
|
| Headache | 2 | 2007 | 43 | 0.340 |
Why?
|
| Transcription Factors | 2 | 2007 | 166 | 0.340 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2016 | 455 | 0.340 |
Why?
|
| Ethics, Medical | 1 | 2009 | 16 | 0.340 |
Why?
|
| Pain | 6 | 2023 | 396 | 0.340 |
Why?
|
| Lactoferrin | 3 | 2013 | 12 | 0.330 |
Why?
|
| Wounds, Penetrating | 2 | 2008 | 10 | 0.320 |
Why?
|
| Smoking | 6 | 2000 | 194 | 0.320 |
Why?
|
| Vertebral Artery | 1 | 2008 | 5 | 0.320 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2016 | 48 | 0.320 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 27 | 0.320 |
Why?
|
| Angiography | 1 | 2008 | 39 | 0.320 |
Why?
|
| Gelatin Sponge, Absorbable | 2 | 2006 | 6 | 0.320 |
Why?
|
| Sex Characteristics | 5 | 2019 | 135 | 0.320 |
Why?
|
| Extracellular Matrix Proteins | 4 | 2012 | 131 | 0.320 |
Why?
|
| Hemostatics | 2 | 2006 | 12 | 0.310 |
Why?
|
| First Aid | 1 | 2008 | 2 | 0.310 |
Why?
|
| Staphylococcal Infections | 3 | 2006 | 176 | 0.310 |
Why?
|
| Cerebral Palsy | 1 | 2008 | 9 | 0.310 |
Why?
|
| Prospective Studies | 15 | 2022 | 1821 | 0.310 |
Why?
|
| Transduction, Genetic | 4 | 2009 | 18 | 0.300 |
Why?
|
| Triage | 1 | 2008 | 23 | 0.300 |
Why?
|
| Neurons, Afferent | 2 | 2007 | 7 | 0.300 |
Why?
|
| Pelvis | 2 | 2023 | 30 | 0.290 |
Why?
|
| Machine Learning | 3 | 2022 | 54 | 0.290 |
Why?
|
| ADAM Proteins | 6 | 2014 | 65 | 0.290 |
Why?
|
| Vertebroplasty | 1 | 2007 | 10 | 0.290 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2023 | 223 | 0.280 |
Why?
|
| Bone Matrix | 4 | 2014 | 28 | 0.280 |
Why?
|
| Species Specificity | 3 | 2014 | 73 | 0.280 |
Why?
|
| Bone Diseases, Infectious | 1 | 2006 | 2 | 0.270 |
Why?
|
| Tissue Adhesions | 1 | 2006 | 13 | 0.270 |
Why?
|
| Thrombin | 1 | 2006 | 12 | 0.270 |
Why?
|
| Orthopedic Fixation Devices | 2 | 2005 | 24 | 0.260 |
Why?
|
| Amides | 2 | 2016 | 21 | 0.260 |
Why?
|
| Emergency Medicine | 1 | 2008 | 79 | 0.260 |
Why?
|
| Recovery of Function | 5 | 2012 | 291 | 0.260 |
Why?
|
| Fractures, Spontaneous | 3 | 2005 | 11 | 0.260 |
Why?
|
| Abscess | 1 | 2006 | 26 | 0.260 |
Why?
|
| Neurofibromatosis 1 | 1 | 2005 | 4 | 0.260 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2005 | 6 | 0.260 |
Why?
|
| Age Factors | 8 | 2019 | 852 | 0.260 |
Why?
|
| Autocrine Communication | 1 | 2005 | 4 | 0.260 |
Why?
|
| fas Receptor | 1 | 2005 | 11 | 0.260 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 18 | 0.260 |
Why?
|
| Paracrine Communication | 1 | 2005 | 6 | 0.260 |
Why?
|
| Spondylosis | 3 | 2017 | 32 | 0.250 |
Why?
|
| Mice | 7 | 2023 | 1629 | 0.250 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2005 | 41 | 0.250 |
Why?
|
| Aggrecans | 5 | 2013 | 155 | 0.250 |
Why?
|
| Debridement | 2 | 2006 | 102 | 0.250 |
Why?
|
| Aquaculture | 2 | 2014 | 2 | 0.240 |
Why?
|
| Spinal Cord | 3 | 2006 | 105 | 0.240 |
Why?
|
| Gene Frequency | 2 | 2014 | 72 | 0.240 |
Why?
|
| Polymorphism, Genetic | 2 | 2014 | 74 | 0.240 |
Why?
|
| Gene Expression | 6 | 2016 | 231 | 0.240 |
Why?
|
| Transplantation, Autologous | 7 | 2012 | 195 | 0.230 |
Why?
|
| Cohort Studies | 9 | 2019 | 1952 | 0.230 |
Why?
|
| Alleles | 2 | 2014 | 216 | 0.230 |
Why?
|
| Brassica | 1 | 2023 | 2 | 0.230 |
Why?
|
| Pandemics | 3 | 2021 | 237 | 0.230 |
Why?
|
| Implants, Experimental | 1 | 2004 | 31 | 0.230 |
Why?
|
| Minimally Invasive Surgical Procedures | 4 | 2023 | 303 | 0.230 |
Why?
|
| Joint Prosthesis | 1 | 2005 | 80 | 0.230 |
Why?
|
| Fibroblast Growth Factor 2 | 4 | 2013 | 23 | 0.230 |
Why?
|
| Osteophyte | 1 | 2023 | 6 | 0.230 |
Why?
|
| Lead Poisoning | 1 | 2023 | 1 | 0.230 |
Why?
|
| Lead | 1 | 2023 | 3 | 0.230 |
Why?
|
| Allografts | 2 | 2015 | 180 | 0.220 |
Why?
|
| Cell Survival | 7 | 2013 | 165 | 0.220 |
Why?
|
| Inbreeding | 2 | 2014 | 3 | 0.220 |
Why?
|
| Severity of Illness Index | 9 | 2015 | 1126 | 0.220 |
Why?
|
| Genotype | 2 | 2014 | 399 | 0.220 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 43 | 0.220 |
Why?
|
| Bone Wires | 4 | 2012 | 12 | 0.220 |
Why?
|
| Biglycan | 3 | 2016 | 17 | 0.210 |
Why?
|
| Torsion Abnormality | 4 | 2007 | 10 | 0.210 |
Why?
|
| Observer Variation | 3 | 2016 | 119 | 0.210 |
Why?
|
| Risk Assessment | 4 | 2021 | 683 | 0.210 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2023 | 101 | 0.210 |
Why?
|
| Pediatric Obesity | 1 | 2023 | 44 | 0.210 |
Why?
|
| Microbiota | 1 | 2023 | 105 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2016 | 463 | 0.200 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 49 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 2 | 2006 | 401 | 0.200 |
Why?
|
| Recurrence | 4 | 2019 | 352 | 0.200 |
Why?
|
| Awards and Prizes | 1 | 2022 | 25 | 0.200 |
Why?
|
| Surveys and Questionnaires | 7 | 2021 | 1186 | 0.200 |
Why?
|
| Lipopolysaccharides | 3 | 2013 | 129 | 0.200 |
Why?
|
| Pseudarthrosis | 4 | 2009 | 13 | 0.200 |
Why?
|
| Carrier Proteins | 4 | 2013 | 99 | 0.200 |
Why?
|
| Prosthesis Design | 3 | 2017 | 494 | 0.190 |
Why?
|
| Spondylitis | 1 | 2001 | 3 | 0.190 |
Why?
|
| Spinal Canal | 5 | 2004 | 15 | 0.190 |
Why?
|
| Prostatic Hyperplasia | 1 | 2021 | 12 | 0.190 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 180 | 0.190 |
Why?
|
| Microspheres | 3 | 2023 | 31 | 0.190 |
Why?
|
| Feasibility Studies | 3 | 2016 | 230 | 0.190 |
Why?
|
| Hematoma | 2 | 2014 | 19 | 0.180 |
Why?
|
| Receptors, CCR1 | 1 | 2020 | 2 | 0.180 |
Why?
|
| Intraoperative Complications | 2 | 2018 | 71 | 0.180 |
Why?
|
| Chemokines, CC | 1 | 2020 | 8 | 0.180 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 32 | 0.180 |
Why?
|
| Anesthesia | 1 | 2021 | 35 | 0.180 |
Why?
|
| Endoscopy | 2 | 2006 | 181 | 0.180 |
Why?
|
| United States | 8 | 2023 | 2344 | 0.180 |
Why?
|
| Drug Therapy, Combination | 1 | 2001 | 245 | 0.180 |
Why?
|
| Dura Mater | 2 | 2018 | 21 | 0.180 |
Why?
|
| Immunohistochemistry | 6 | 2015 | 411 | 0.180 |
Why?
|
| Ilium | 3 | 2012 | 31 | 0.180 |
Why?
|
| Prosthesis Failure | 2 | 2017 | 530 | 0.180 |
Why?
|
| Forecasting | 4 | 2006 | 117 | 0.170 |
Why?
|
| Odds Ratio | 1 | 2021 | 286 | 0.170 |
Why?
|
| Cell Differentiation | 2 | 2018 | 149 | 0.170 |
Why?
|
| Nerve Growth Factor | 3 | 2015 | 33 | 0.170 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 42 | 0.170 |
Why?
|
| Orthopedic Surgeons | 1 | 2020 | 27 | 0.170 |
Why?
|
| Models, Animal | 3 | 2018 | 128 | 0.170 |
Why?
|
| Blotting, Western | 6 | 2015 | 175 | 0.170 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 38 | 0.170 |
Why?
|
| Leg | 1 | 2019 | 49 | 0.170 |
Why?
|
| Interleukin-4 | 1 | 2019 | 35 | 0.170 |
Why?
|
| Cytokines | 4 | 2023 | 350 | 0.170 |
Why?
|
| DNA | 7 | 2009 | 122 | 0.170 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2019 | 36 | 0.170 |
Why?
|
| Hip Joint | 1 | 2023 | 357 | 0.160 |
Why?
|
| Analgesia | 1 | 2019 | 38 | 0.160 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 129 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 75 | 0.160 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 149 | 0.160 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 61 | 0.160 |
Why?
|
| Recombinant Proteins | 4 | 2014 | 254 | 0.160 |
Why?
|
| Prognosis | 5 | 2019 | 874 | 0.160 |
Why?
|
| Ligamentum Flavum | 2 | 2015 | 6 | 0.160 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 33 | 0.160 |
Why?
|
| Perioperative Care | 1 | 1999 | 53 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 156 | 0.160 |
Why?
|
| Transplantation, Heterologous | 1 | 2018 | 20 | 0.160 |
Why?
|
| Disabled Persons | 1 | 2020 | 129 | 0.160 |
Why?
|
| Torque | 2 | 2017 | 28 | 0.160 |
Why?
|
| Predictive Value of Tests | 6 | 2022 | 532 | 0.160 |
Why?
|
| Absorptiometry, Photon | 5 | 2005 | 84 | 0.160 |
Why?
|
| Constriction, Pathologic | 2 | 2017 | 27 | 0.160 |
Why?
|
| Random Allocation | 3 | 2015 | 143 | 0.160 |
Why?
|
| Watchful Waiting | 1 | 2018 | 9 | 0.160 |
Why?
|
| Orchiectomy | 1 | 2018 | 5 | 0.160 |
Why?
|
| Organ Culture Techniques | 5 | 2013 | 29 | 0.160 |
Why?
|
| Graft Survival | 2 | 2015 | 98 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 86 | 0.150 |
Why?
|
| Software | 2 | 2016 | 72 | 0.150 |
Why?
|
| Osteoarthritis, Spine | 2 | 2015 | 7 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 89 | 0.150 |
Why?
|
| Testicular Neoplasms | 1 | 2018 | 23 | 0.150 |
Why?
|
| Diagnosis, Differential | 6 | 2001 | 398 | 0.150 |
Why?
|
| Incidental Findings | 1 | 2018 | 16 | 0.150 |
Why?
|
| Hydrocephalus | 1 | 2018 | 28 | 0.150 |
Why?
|
| Sodium Chloride | 1 | 1998 | 37 | 0.150 |
Why?
|
| Arthrography | 2 | 2010 | 27 | 0.150 |
Why?
|
| Goats | 3 | 2014 | 10 | 0.150 |
Why?
|
| Peptide Fragments | 3 | 2014 | 96 | 0.150 |
Why?
|
| Materials Testing | 2 | 2017 | 136 | 0.150 |
Why?
|
| Adipose Tissue | 1 | 2018 | 74 | 0.150 |
Why?
|
| Cerebral Veins | 1 | 2017 | 4 | 0.150 |
Why?
|
| Radiologists | 1 | 2017 | 6 | 0.150 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 7 | 0.150 |
Why?
|
| Rats, Wistar | 2 | 2008 | 45 | 0.140 |
Why?
|
| Receptors, CCR5 | 1 | 2017 | 29 | 0.140 |
Why?
|
| SOX9 Transcription Factor | 4 | 2013 | 14 | 0.140 |
Why?
|
| Lipomatosis | 1 | 2016 | 4 | 0.140 |
Why?
|
| Sensory System Agents | 1 | 2016 | 4 | 0.140 |
Why?
|
| Capsaicin | 1 | 2016 | 11 | 0.140 |
Why?
|
| Substance P | 1 | 2016 | 18 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 79 | 0.140 |
Why?
|
| Cell Proliferation | 7 | 2016 | 206 | 0.140 |
Why?
|
| Clinical Trials as Topic | 2 | 2012 | 337 | 0.140 |
Why?
|
| Arthroplasty | 1 | 2017 | 138 | 0.140 |
Why?
|
| Chondroitin ABC Lyase | 2 | 2007 | 6 | 0.140 |
Why?
|
| Cerebral Hemorrhage | 1 | 2018 | 131 | 0.140 |
Why?
|
| Interleukin-7 | 1 | 2016 | 23 | 0.140 |
Why?
|
| Manipulation, Spinal | 1 | 2016 | 5 | 0.140 |
Why?
|
| Torsion, Mechanical | 1 | 2016 | 4 | 0.140 |
Why?
|
| Interleukin-10 | 1 | 2016 | 36 | 0.130 |
Why?
|
| rho-Associated Kinases | 1 | 2016 | 6 | 0.130 |
Why?
|
| Blood Platelets | 2 | 2006 | 50 | 0.130 |
Why?
|
| Casts, Surgical | 2 | 1997 | 8 | 0.130 |
Why?
|
| Prosthesis Implantation | 2 | 2010 | 35 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 132 | 0.130 |
Why?
|
| Adenoviridae | 4 | 2009 | 19 | 0.130 |
Why?
|
| Catheters, Indwelling | 1 | 2016 | 26 | 0.130 |
Why?
|
| Pyridines | 1 | 2016 | 45 | 0.130 |
Why?
|
| Gadolinium | 2 | 1998 | 10 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 329 | 0.130 |
Why?
|
| Equipment Design | 1 | 2016 | 185 | 0.130 |
Why?
|
| Analgesia, Epidural | 1 | 2016 | 60 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 2 | 2005 | 40 | 0.130 |
Why?
|
| Neuralgia | 1 | 2015 | 15 | 0.130 |
Why?
|
| Tissue Preservation | 1 | 1995 | 6 | 0.130 |
Why?
|
| Cell Division | 4 | 2008 | 112 | 0.130 |
Why?
|
| Spinal Nerves | 2 | 2010 | 6 | 0.130 |
Why?
|
| Joint Capsule | 1 | 2015 | 43 | 0.120 |
Why?
|
| Graft Rejection | 1 | 2015 | 75 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2015 | 113 | 0.120 |
Why?
|
| Marine Biology | 1 | 2014 | 1 | 0.120 |
Why?
|
| Genetic Drift | 1 | 2014 | 1 | 0.120 |
Why?
|
| Fisheries | 1 | 2014 | 1 | 0.120 |
Why?
|
| Reference Values | 6 | 2009 | 230 | 0.120 |
Why?
|
| Child | 5 | 2022 | 1376 | 0.120 |
Why?
|
| Geography | 1 | 2014 | 22 | 0.120 |
Why?
|
| Longitudinal Ligaments | 1 | 2014 | 2 | 0.120 |
Why?
|
| Patient Selection | 4 | 2010 | 234 | 0.120 |
Why?
|
| Aging | 6 | 2012 | 1630 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 73 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2023 | 402 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2014 | 44 | 0.120 |
Why?
|
| Neuroprotective Agents | 2 | 2005 | 60 | 0.120 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2013 | 58 | 0.120 |
Why?
|
| Iohexol | 1 | 2013 | 5 | 0.120 |
Why?
|
| Iopamidol | 1 | 2013 | 3 | 0.120 |
Why?
|
| Bone and Bones | 2 | 2012 | 124 | 0.110 |
Why?
|
| Analysis of Variance | 5 | 2015 | 325 | 0.110 |
Why?
|
| Neck | 3 | 2023 | 33 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2014 | 310 | 0.110 |
Why?
|
| Lidocaine | 1 | 2013 | 43 | 0.110 |
Why?
|
| Stroke | 1 | 2017 | 294 | 0.110 |
Why?
|
| Diabetes Complications | 1 | 1993 | 64 | 0.110 |
Why?
|
| Phenotype | 3 | 2022 | 362 | 0.110 |
Why?
|
| Transplantation, Homologous | 3 | 2003 | 279 | 0.110 |
Why?
|
| Bupivacaine | 1 | 2013 | 54 | 0.110 |
Why?
|
| Genetic Vectors | 3 | 2008 | 63 | 0.110 |
Why?
|
| Neurons | 1 | 2016 | 380 | 0.110 |
Why?
|
| Algorithms | 3 | 2022 | 400 | 0.110 |
Why?
|
| Staphylococcus aureus | 2 | 2006 | 85 | 0.110 |
Why?
|
| Biological Factors | 1 | 2013 | 9 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2014 | 178 | 0.110 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2013 | 44 | 0.110 |
Why?
|
| Menisci, Tibial | 1 | 2015 | 172 | 0.110 |
Why?
|
| Fibroblast Growth Factors | 2 | 2013 | 8 | 0.110 |
Why?
|
| Orthopedic Equipment | 2 | 2006 | 7 | 0.100 |
Why?
|
| Physical Stimulation | 1 | 2012 | 12 | 0.100 |
Why?
|
| Glycerol | 1 | 2012 | 3 | 0.100 |
Why?
|
| Tibial Fractures | 2 | 1990 | 13 | 0.100 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 147 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 16 | 0.100 |
Why?
|
| Protein Kinase C-delta | 1 | 2011 | 11 | 0.100 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 91 | 0.100 |
Why?
|
| Blood Loss, Surgical | 3 | 2019 | 66 | 0.100 |
Why?
|
| Fracture Healing | 1 | 2012 | 41 | 0.100 |
Why?
|
| Up-Regulation | 5 | 2015 | 173 | 0.100 |
Why?
|
| Procollagen N-Endopeptidase | 2 | 2008 | 16 | 0.100 |
Why?
|
| Infant | 3 | 2022 | 542 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2012 | 131 | 0.100 |
Why?
|
| Incidence | 3 | 2021 | 759 | 0.090 |
Why?
|
| Preoperative Care | 1 | 2012 | 135 | 0.090 |
Why?
|
| Combined Modality Therapy | 3 | 2005 | 376 | 0.090 |
Why?
|
| Metabolism | 2 | 2010 | 9 | 0.090 |
Why?
|
| Arthrodesis | 3 | 2023 | 40 | 0.090 |
Why?
|
| Biopsy | 3 | 2015 | 239 | 0.090 |
Why?
|
| Psoas Muscles | 1 | 2010 | 6 | 0.090 |
Why?
|
| Intervertebral Disc Chemolysis | 2 | 2007 | 5 | 0.090 |
Why?
|
| Osteoarthritis, Knee | 1 | 2015 | 382 | 0.090 |
Why?
|
| Patient Rights | 1 | 2009 | 3 | 0.090 |
Why?
|
| Injections, Spinal | 2 | 2007 | 53 | 0.080 |
Why?
|
| Conflict of Interest | 1 | 2009 | 18 | 0.080 |
Why?
|
| Femoral Neck Fractures | 1 | 1989 | 13 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2009 | 106 | 0.080 |
Why?
|
| Fractures, Closed | 1 | 1989 | 2 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2007 | 508 | 0.080 |
Why?
|
| Ulna Fractures | 1 | 1989 | 7 | 0.080 |
Why?
|
| Phytoestrogens | 1 | 2008 | 3 | 0.080 |
Why?
|
| Stilbenes | 1 | 2008 | 5 | 0.080 |
Why?
|
| Dupuytren Contracture | 1 | 1988 | 1 | 0.080 |
Why?
|
| Hip Fractures | 1 | 1989 | 33 | 0.080 |
Why?
|
| Fruit | 1 | 2008 | 24 | 0.080 |
Why?
|
| Chemotaxis | 1 | 2008 | 6 | 0.080 |
Why?
|
| Solubility | 1 | 2008 | 36 | 0.080 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 31 | 0.080 |
Why?
|
| Pubic Bone | 1 | 1988 | 3 | 0.080 |
Why?
|
| Reflex Sympathetic Dystrophy | 1 | 1988 | 6 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2013 | 159 | 0.080 |
Why?
|
| Lifting | 1 | 2008 | 4 | 0.080 |
Why?
|
| Paralysis | 2 | 1992 | 19 | 0.080 |
Why?
|
| Single-Blind Method | 2 | 2005 | 120 | 0.080 |
Why?
|
| Injections | 2 | 2005 | 57 | 0.080 |
Why?
|
| Pulmonary Embolism | 2 | 1997 | 59 | 0.080 |
Why?
|
| Bone Diseases | 1 | 2008 | 24 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 31 | 0.080 |
Why?
|
| Genes, Reporter | 1 | 2007 | 29 | 0.080 |
Why?
|
| Caspases | 1 | 2007 | 33 | 0.080 |
Why?
|
| Postoperative Period | 3 | 2019 | 286 | 0.070 |
Why?
|
| Endopeptidases | 1 | 2007 | 30 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 43 | 0.070 |
Why?
|
| Porosity | 4 | 2011 | 69 | 0.070 |
Why?
|
| Fibromodulin | 2 | 2009 | 15 | 0.070 |
Why?
|
| Decorin | 2 | 2009 | 17 | 0.070 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2009 | 29 | 0.070 |
Why?
|
| Physical Therapy Modalities | 1 | 2008 | 81 | 0.070 |
Why?
|
| Growth Differentiation Factor 5 | 2 | 2023 | 8 | 0.070 |
Why?
|
| Encephalitis | 1 | 1987 | 18 | 0.070 |
Why?
|
| Cryoglobulinemia | 1 | 1987 | 2 | 0.070 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 221 | 0.070 |
Why?
|
| Axons | 1 | 2007 | 38 | 0.070 |
Why?
|
| Anterior Compartment Syndrome | 1 | 1987 | 1 | 0.070 |
Why?
|
| Antigens | 1 | 2007 | 27 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 107 | 0.070 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2007 | 33 | 0.070 |
Why?
|
| Femoral Nerve | 1 | 1987 | 9 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 1988 | 106 | 0.070 |
Why?
|
| Synovitis | 1 | 1987 | 22 | 0.070 |
Why?
|
| Heparin | 1 | 1987 | 26 | 0.070 |
Why?
|
| Osteolysis | 1 | 1988 | 138 | 0.070 |
Why?
|
| Muscular Diseases | 1 | 1987 | 18 | 0.070 |
Why?
|
| Thigh | 1 | 1987 | 35 | 0.070 |
Why?
|
| Matrix Metalloproteinase 13 | 3 | 2014 | 31 | 0.070 |
Why?
|
| Compartment Syndromes | 1 | 1987 | 12 | 0.070 |
Why?
|
| Sciatic Nerve | 1 | 1987 | 32 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 334 | 0.070 |
Why?
|
| Nerve Fibers | 1 | 2006 | 15 | 0.070 |
Why?
|
| Injections, Intralesional | 1 | 2006 | 29 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2006 | 46 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 55 | 0.070 |
Why?
|
| Fibrocartilage | 1 | 2006 | 9 | 0.070 |
Why?
|
| Sports | 1 | 1987 | 37 | 0.070 |
Why?
|
| Surgical Wound Infection | 2 | 2006 | 98 | 0.070 |
Why?
|
| Plasma | 1 | 2006 | 34 | 0.070 |
Why?
|
| Joints | 3 | 2008 | 99 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 55 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2017 | 81 | 0.070 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2006 | 9 | 0.070 |
Why?
|
| Blood Sedimentation | 1 | 2006 | 64 | 0.070 |
Why?
|
| Creatine Kinase | 1 | 2006 | 33 | 0.070 |
Why?
|
| Therapeutic Irrigation | 1 | 2006 | 66 | 0.070 |
Why?
|
| Cricetinae | 1 | 2005 | 37 | 0.070 |
Why?
|
| Hip Dislocation | 1 | 1987 | 64 | 0.070 |
Why?
|
| Tendons | 1 | 2008 | 223 | 0.070 |
Why?
|
| Research | 1 | 2006 | 55 | 0.070 |
Why?
|
| Shoulder | 1 | 1987 | 158 | 0.070 |
Why?
|
| Ultrasonic Therapy | 1 | 2005 | 20 | 0.060 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2005 | 3 | 0.060 |
Why?
|
| Abdominal Muscles | 1 | 1985 | 8 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 16 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2005 | 101 | 0.060 |
Why?
|
| Ovariectomy | 1 | 2005 | 28 | 0.060 |
Why?
|
| Baseball | 1 | 1987 | 107 | 0.060 |
Why?
|
| Wounds, Stab | 1 | 2005 | 1 | 0.060 |
Why?
|
| Wound Healing | 2 | 2005 | 168 | 0.060 |
Why?
|
| Water | 1 | 2005 | 33 | 0.060 |
Why?
|
| Athletic Injuries | 1 | 1987 | 180 | 0.060 |
Why?
|
| Needles | 1 | 2005 | 18 | 0.060 |
Why?
|
| Glucuronic Acid | 3 | 2013 | 9 | 0.060 |
Why?
|
| Hexuronic Acids | 3 | 2013 | 10 | 0.060 |
Why?
|
| Alginates | 3 | 2013 | 10 | 0.060 |
Why?
|
| Motion | 2 | 2001 | 23 | 0.060 |
Why?
|
| Bony Callus | 1 | 2004 | 8 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2016 | 640 | 0.060 |
Why?
|
| Titanium | 1 | 2005 | 197 | 0.060 |
Why?
|
| Seedlings | 1 | 2023 | 5 | 0.060 |
Why?
|
| Spinal Injuries | 2 | 2008 | 28 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2003 | 29 | 0.060 |
Why?
|
| Plant Extracts | 1 | 2023 | 16 | 0.060 |
Why?
|
| Medicine, Ayurvedic | 1 | 2023 | 1 | 0.060 |
Why?
|
| Biolistics | 1 | 2003 | 1 | 0.060 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2023 | 6 | 0.060 |
Why?
|
| Hypesthesia | 1 | 2023 | 8 | 0.060 |
Why?
|
| Probability | 1 | 2003 | 93 | 0.060 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2023 | 15 | 0.060 |
Why?
|
| Microscopy, Polarization | 1 | 2003 | 2 | 0.060 |
Why?
|
| Sacroiliac Joint | 1 | 2023 | 9 | 0.060 |
Why?
|
| Hydrogels | 1 | 2023 | 9 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2003 | 31 | 0.050 |
Why?
|
| Bacteria | 1 | 2023 | 76 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2023 | 55 | 0.050 |
Why?
|
| Oxygen | 1 | 2023 | 86 | 0.050 |
Why?
|
| Outpatients | 1 | 2023 | 54 | 0.050 |
Why?
|
| Alternative Splicing | 2 | 2015 | 24 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2023 | 39 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 355 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2015 | 52 | 0.050 |
Why?
|
| Versicans | 1 | 2002 | 17 | 0.050 |
Why?
|
| Marfan Syndrome | 1 | 2002 | 3 | 0.050 |
Why?
|
| Pressure | 1 | 2002 | 61 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2002 | 112 | 0.050 |
Why?
|
| Sex Factors | 3 | 2011 | 497 | 0.050 |
Why?
|
| Hospitals | 1 | 2023 | 157 | 0.050 |
Why?
|
| Linear Models | 2 | 2020 | 258 | 0.050 |
Why?
|
| Workers' Compensation | 1 | 2002 | 59 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2013 | 66 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2022 | 27 | 0.050 |
Why?
|
| Receptor, trkA | 2 | 2015 | 9 | 0.050 |
Why?
|
| Cell Line, Transformed | 2 | 2016 | 17 | 0.050 |
Why?
|
| ADAMTS5 Protein | 2 | 2014 | 28 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2015 | 36 | 0.050 |
Why?
|
| Consensus | 1 | 2022 | 109 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2001 | 55 | 0.050 |
Why?
|
| Pliability | 1 | 2001 | 1 | 0.050 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 79 | 0.050 |
Why?
|
| Paraspinal Muscles | 1 | 2020 | 2 | 0.050 |
Why?
|
| Neck Muscles | 1 | 2020 | 13 | 0.050 |
Why?
|
| Knee Joint | 1 | 1987 | 800 | 0.050 |
Why?
|
| Electromagnetic Fields | 1 | 2000 | 13 | 0.050 |
Why?
|
| Perception | 1 | 2021 | 83 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 2 | 2012 | 22 | 0.040 |
Why?
|
| Fetal Blood | 2 | 2013 | 17 | 0.040 |
Why?
|
| Electric Stimulation Therapy | 1 | 2000 | 47 | 0.040 |
Why?
|
| Global Health | 1 | 2020 | 55 | 0.040 |
Why?
|
| Intermittent Claudication | 1 | 2019 | 4 | 0.040 |
Why?
|
| Cryoultramicrotomy | 1 | 1999 | 2 | 0.040 |
Why?
|
| Ligaments | 1 | 2000 | 15 | 0.040 |
Why?
|
| Pelvic Bones | 1 | 2019 | 20 | 0.040 |
Why?
|
| Dissection | 1 | 1999 | 27 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2011 | 110 | 0.040 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2019 | 2 | 0.040 |
Why?
|
| Ligaments, Articular | 1 | 2000 | 104 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 388 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2000 | 143 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 10 | 0.040 |
Why?
|
| Operative Time | 1 | 2019 | 81 | 0.040 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 80 | 0.040 |
Why?
|
| Myelography | 2 | 2001 | 10 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2021 | 425 | 0.040 |
Why?
|
| Length of Stay | 2 | 2017 | 320 | 0.040 |
Why?
|
| Decision Making | 1 | 2000 | 227 | 0.040 |
Why?
|
| Analgesics | 1 | 2019 | 108 | 0.040 |
Why?
|
| ADAMTS4 Protein | 2 | 2008 | 18 | 0.040 |
Why?
|
| Rats, Nude | 1 | 2018 | 4 | 0.040 |
Why?
|
| Retroperitoneal Space | 1 | 2018 | 13 | 0.040 |
Why?
|
| Ontario | 1 | 2018 | 17 | 0.040 |
Why?
|
| Lymph Node Excision | 1 | 2018 | 27 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2018 | 65 | 0.040 |
Why?
|
| Cerebral Ventricles | 1 | 2018 | 23 | 0.040 |
Why?
|
| Cell Count | 2 | 2013 | 97 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 95 | 0.040 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 18 | 0.040 |
Why?
|
| Stem Cells | 1 | 2018 | 49 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2008 | 112 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 970 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2018 | 310 | 0.040 |
Why?
|
| Patient Care Team | 1 | 1999 | 141 | 0.040 |
Why?
|
| Joint Dislocations | 2 | 1994 | 58 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 364 | 0.040 |
Why?
|
| Survival Rate | 1 | 2018 | 376 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2017 | 68 | 0.040 |
Why?
|
| Databases, Bibliographic | 1 | 2016 | 12 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 1997 | 34 | 0.030 |
Why?
|
| Swine, Miniature | 2 | 2006 | 4 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 1997 | 48 | 0.030 |
Why?
|
| Swine | 2 | 2006 | 83 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 331 | 0.030 |
Why?
|
| Posture | 1 | 2016 | 79 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2016 | 27 | 0.030 |
Why?
|
| Ceramics | 1 | 1995 | 23 | 0.030 |
Why?
|
| Visual Analog Scale | 1 | 2016 | 49 | 0.030 |
Why?
|
| Freeze Drying | 1 | 1995 | 1 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 69 | 0.030 |
Why?
|
| Astrocytes | 1 | 2016 | 122 | 0.030 |
Why?
|
| Cryopreservation | 1 | 1995 | 25 | 0.030 |
Why?
|
| Esophagus | 1 | 1995 | 58 | 0.030 |
Why?
|
| Sternum | 1 | 1994 | 5 | 0.030 |
Why?
|
| Heterocyclic Compounds | 1 | 1994 | 11 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2016 | 112 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 2015 | 79 | 0.030 |
Why?
|
| Remission, Spontaneous | 1 | 2014 | 10 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 13 | 0.030 |
Why?
|
| Transfection | 1 | 2014 | 128 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 46 | 0.030 |
Why?
|
| Biomarkers | 1 | 2017 | 704 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 1997 | 221 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2013 | 28 | 0.030 |
Why?
|
| Gout | 1 | 1993 | 8 | 0.030 |
Why?
|
| Prevalence | 1 | 2015 | 494 | 0.030 |
Why?
|
| Ribs | 1 | 1993 | 16 | 0.030 |
Why?
|
| Diagnostic Errors | 2 | 2009 | 40 | 0.030 |
Why?
|
| Smad6 Protein | 1 | 2013 | 3 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 11 | 0.030 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2013 | 1 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 2 | 0.030 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 19 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 89 | 0.030 |
Why?
|
| Chondrogenesis | 1 | 2013 | 30 | 0.030 |
Why?
|
| Intraoperative Period | 2 | 2003 | 33 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2012 | 12 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 44 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2012 | 5 | 0.030 |
Why?
|
| Anabolic Agents | 1 | 2012 | 6 | 0.030 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 33 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 53 | 0.030 |
Why?
|
| Regression Analysis | 3 | 2000 | 298 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 65 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 38 | 0.030 |
Why?
|
| Pregabalin | 1 | 2011 | 22 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2012 | 71 | 0.020 |
Why?
|
| Epiphyses, Slipped | 1 | 1991 | 1 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 1993 | 158 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2012 | 96 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2011 | 49 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 1991 | 24 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2010 | 6 | 0.020 |
Why?
|
| Femur Head | 1 | 1991 | 65 | 0.020 |
Why?
|
| Wounds, Gunshot | 1 | 1990 | 3 | 0.020 |
Why?
|
| Permeability | 1 | 2010 | 138 | 0.020 |
Why?
|
| Fractures, Open | 1 | 1990 | 3 | 0.020 |
Why?
|
| Biometry | 1 | 2009 | 6 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2009 | 8 | 0.020 |
Why?
|
| Surgical Flaps | 2 | 2006 | 50 | 0.020 |
Why?
|
| Collagen Type X | 1 | 2009 | 2 | 0.020 |
Why?
|
| Lumican | 1 | 2009 | 3 | 0.020 |
Why?
|
| Supination | 1 | 1989 | 19 | 0.020 |
Why?
|
| Vitis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Keratan Sulfate | 1 | 2009 | 27 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2008 | 9 | 0.020 |
Why?
|
| DNA Replication | 1 | 2008 | 12 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 29 | 0.020 |
Why?
|
| Microcirculation | 1 | 1988 | 39 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 36 | 0.020 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2008 | 6 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 1988 | 53 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2010 | 618 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 28 | 0.020 |
Why?
|
| Observation | 1 | 2008 | 16 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2008 | 50 | 0.020 |
Why?
|
| Body Water | 1 | 2007 | 4 | 0.020 |
Why?
|
| Cathepsins | 1 | 2007 | 7 | 0.020 |
Why?
|
| Caspase Inhibitors | 1 | 2007 | 5 | 0.020 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2007 | 4 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2007 | 5 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2007 | 12 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2007 | 11 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1462 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2007 | 30 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2008 | 114 | 0.020 |
Why?
|
| Accidental Falls | 1 | 1989 | 117 | 0.020 |
Why?
|
| Oxidants | 1 | 2007 | 29 | 0.020 |
Why?
|
| Scapula | 1 | 1988 | 81 | 0.020 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2007 | 1 | 0.020 |
Why?
|
| GAP-43 Protein | 1 | 2007 | 2 | 0.020 |
Why?
|
| Elbow Joint | 1 | 1989 | 131 | 0.020 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2007 | 7 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2007 | 202 | 0.020 |
Why?
|
| Cell Communication | 1 | 2007 | 29 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 56 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1989 | 654 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 2007 | 97 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1987 | 12 | 0.020 |
Why?
|
| Punctures | 1 | 2006 | 10 | 0.020 |
Why?
|
| Platelet Count | 1 | 2006 | 22 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2006 | 7 | 0.020 |
Why?
|
| Education | 1 | 2006 | 40 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2006 | 50 | 0.020 |
Why?
|
| Coccyx | 1 | 2005 | 1 | 0.020 |
Why?
|
| Radiosurgery | 1 | 2006 | 34 | 0.020 |
Why?
|
| Fractures, Compression | 1 | 2005 | 7 | 0.020 |
Why?
|
| Laparotomy | 1 | 1985 | 22 | 0.020 |
Why?
|
| Tail | 1 | 2005 | 4 | 0.020 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2005 | 5 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2005 | 30 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 2005 | 53 | 0.020 |
Why?
|
| ROC Curve | 1 | 2002 | 140 | 0.010 |
Why?
|
| Sciatica | 1 | 2001 | 3 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2001 | 18 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 332 | 0.010 |
Why?
|
| Edema | 1 | 2001 | 39 | 0.010 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 2001 | 4 | 0.010 |
Why?
|
| Logistic Models | 1 | 2002 | 410 | 0.010 |
Why?
|
| Nonlinear Dynamics | 1 | 2001 | 15 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2000 | 57 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2000 | 110 | 0.010 |
Why?
|
| Macrophages | 1 | 2000 | 128 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 1998 | 4 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1998 | 44 | 0.010 |
Why?
|
| Emergency Medical Technicians | 1 | 1997 | 2 | 0.010 |
Why?
|
| Transportation of Patients | 1 | 1997 | 6 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 54 | 0.010 |
Why?
|
| Resuscitation | 1 | 1997 | 18 | 0.010 |
Why?
|
| Medical History Taking | 1 | 1997 | 24 | 0.010 |
Why?
|
| Physical Examination | 1 | 1997 | 117 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 1997 | 161 | 0.010 |
Why?
|
| Papio | 1 | 1995 | 9 | 0.010 |
Why?
|
| Equipment Failure | 1 | 1995 | 53 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1993 | 60 | 0.010 |
Why?
|
| Reflex, Abnormal | 1 | 1993 | 1 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1993 | 14 | 0.010 |
Why?
|
| Fracture Fixation | 1 | 1993 | 26 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 224 | 0.010 |
Why?
|
| Wound Infection | 1 | 1990 | 13 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1990 | 150 | 0.000 |
Why?
|
| Sternoclavicular Joint | 1 | 1988 | 6 | 0.000 |
Why?
|
| Acromioclavicular Joint | 1 | 1988 | 18 | 0.000 |
Why?
|
| Muscles | 1 | 1988 | 73 | 0.000 |
Why?
|